Home › Funds › Point72 Asset Management › TSBX

Point72 Asset Management position in TSBX

TURNSTONE BIOLOGICS CORP

Latest position (Q2 2025)816.92K sh
Reported value held$293.27K
Portfolio Weight0.00%
First reportedQ3 2023
Last changeReduce

Quarter by quarter

QuarterSharesValueChange
Q3 2023 833.33K $3.28M New
Q4 2023 833.33K $2.12M Hold
Q1 2024 1.18M $3.10M Add
Q2 2024 1.12M $2.93M Reduce
Q3 2024 932.23K $519.34K Reduce
Q4 2024 934.36K $464.29K Hold
Q1 2025 878.93K $360.36K Reduce
Q2 2025 816.92K $293.27K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding TSBX

No other tracked fund reports a position in TSBX.

All TSBX fund holders →